Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Blood Test: Molecular analysis of peripheral blood samples through different proprietary techniques to understand presence or absence of malignancy
Sponsors
Epigeneres Biotech Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Healthy individuals: 1. 18 years and above healthy individuals will be included in the study. 2. Individuals with no prior history of cancer will be included. Cancer patients: 1. 18 years and above cancer patients will be included in the study. 2. Cancer patients will be confirmed on histopathology irrespective of grade and stage.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Age less than 18 years. 2. Verified biohazard samples will be excluded. 3. Cancer subjects who have received anticancer treatment within 7 days of sample collection 4. Subjects who have undergone surgery within previous 2 weeks of sample collection 5. Pregnant/ lactating females 6. Subjects who have received growth factors in past 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of cancer and non-cancer subjects using biochemical fingerprints of Raman Spectroscopy, gene expression patterns of qPCR and rare stem cells enumeration using Flow cytometry. â?¢ Identification of primary impacted organ using altered gene expression patterns and mutations profile wherever applicable.Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr Kshama Pansare
Epigeneres Biotech Pvt Ltd
Outcome results
None listed